Though major tech developers like Apple and Google-owned Fitbit have taken center stage in the race to infuse wearable technology with as many health-tracking capabilities as possible, a small startup out of Israel has quietly lapped them all.
Back in 2019, Biobeat lept well ahead of the pack with FDA clearance for its smartwatch and chest patch, making them the first devices cleared to measure blood pressure using only sensors, without requiring an inflatable cuff. Its competitors are scrambling to this day to add blood pressure monitoring to their own wireless wearables.
With the clinical and over-the-counter rollout of Biobeat’s system well underway, the company is now doubling back to add even more features to its remote health monitoring devices. This week, the company announced that the FDA has greenlit respiratory rate and body temperature tracking.
